Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy

NCT00571116 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Halted because of slow accrual and lack of study funding

Conditions

Metastatic Melanoma

Interventions

DRUG: Disulfiram
DRUG: Arsenic trioxide

Sponsor

University of California, Irvine